Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elective hysterectomy.

P Cole, J Berlin

    American Journal of Obstetrics and Gynecology
    |September 15, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Elective hysterectomy offers limited life expectancy gains, primarily benefiting women who would have died from uterine cancers. The procedure

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Palliative and supportive care underutilization for patients with locally advanced pancreatic cancer: review of the NCDB.

    ESMO gastrointestinal oncology·2026
    Same author

    Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancer.

    ESMO open·2025
    Same author

    The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022.

    ESMO open·2023
    Same author

    Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2016
    Same author

    A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2016
    Same author

    A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2015
    Same journal

    Likelihood ratios enhance clinical interpretation of metagenomic prediction of early-onset neonatal sepsis in preterm premature rupture of membranes (Letter-to-the-Editor).

    American journal of obstetrics and gynecology·2026
    Same journal

    Taking risk stratification in preterm premature rupture of membranes to the bedside (Reply to Letter-to-the-Editor).

    American journal of obstetrics and gynecology·2026
    Same journal

    Gestational Age at Full-Term Delivery and Long-Term Offspring Morbidity in Low-Risk Pregnancies: A Population-Based Cohort Study.

    American journal of obstetrics and gynecology·2026
    Same journal

    Trajectories of childbirth-related posttraumatic stress symptoms after a vaginal delivery: a multicenter prospective study.

    American journal of obstetrics and gynecology·2026
    Same journal

    Early life adversity and polycystic ovary syndrome among North American pregnancy planners.

    American journal of obstetrics and gynecology·2026
    Same journal

    Survival assessment of adjuvant chemotherapy for cytology-negative, non-myoinvasive stage IC clear cell endometrial cancer.

    American journal of obstetrics and gynecology·2026
    See all related articles

    Area of Science:

    • Gynecology
    • Public Health
    • Health Economics

    Background:

    • Hysterectomy is a common major surgical procedure.
    • Increasingly performed for elective reasons like cancer prophylaxis, contraception, and menopausal symptom management.
    • Evaluation of elective simple hysterectomy's impact on morbidity, mortality, and cost is crucial.

    Purpose of the Study:

    • To evaluate the effects of elective simple hysterectomy.
    • To analyze morbidity and mortality rates associated with the procedure.
    • To assess the economic implications and life expectancy gains.

    Main Methods:

    • Analysis of data for women undergoing hysterectomy at age 35.
    • Calculation of overall life expectancy gains.
    • Estimation of cancer prevention benefits and associated costs.

    Related Experiment Videos

    Main Results:

    • Average overall life expectancy gain is 0.2 years for women at age 35.
    • 1.3% of women are saved from death by uterine cancers, gaining 14.3 years.
    • 3% are spared uterine cancer development; all gain relief from menopausal bleeding.

    Conclusions:

    • Cancer prophylaxis alone does not justify elective hysterectomy.
    • Adverse health effects may negate cancer prevention benefits.
    • Cost-effectiveness varies, with later surgery and oophorectomy potentially reducing cost per life-year gained but increasing health risks.